about
Age-related glutamate and glutamine concentration changes in normal human brain: 1H MR spectroscopy study at 4 TThe Role of Ephs and Ephrins in Memory FormationMemantine and cholinesterase inhibitors: complementary mechanisms in the treatment of Alzheimer's diseaseThe glutamatergic system and neurodegeneration in dementia: preventive strategies in Alzheimer's diseaseCan zebrafish be used as animal model to study Alzheimer's disease?Altered mRNA editing and expression of ionotropic glutamate receptors after kainic acid exposure in cyclooxygenase-2 deficient mice.Memantine improves cognition and reduces Alzheimer's-like neuropathology in transgenic mice.Glucocorticoid control of glial gene expression.Alzheimer's disease: is a vaccine possible?Spermine modulation of the glutamate(NMDA) receptor is differentially responsive to conantokins in normal and Alzheimer's disease human cerebral cortex.Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of later life.Milacemide: a placebo-controlled study in senile dementia of the Alzheimer type.NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK/MAPK activation.Mechanisms of Alzheimer's Disease Pathogenesis and Prevention: The Brain, Neural Pathology, N-methyl-D-aspartate Receptors, Tau Protein and Other Risk Factors.Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patientsInfluence of pre-existing dementia on the risk of post-stroke epileptic seizures.Current concepts in therapeutic strategies targeting cognitive decline and disease modification in Alzheimer's disease.Riluzole rescues glutamate alterations, cognitive deficits, and tau pathology associated with P301L tau expressionGene Therapy Models of Alzheimer's Disease and Other Dementias.Compartmentalization of excitatory amino acid receptors in human striatum.Presenilin-1/γ-secretase controls glutamate release, tyrosine phosphorylation, and surface expression of N-methyl-D-aspartate receptor (NMDAR) subunit GluN2B.Severe psychological stress in elderly individuals: a proposed model of neurodegeneration and its implications.The role of adenosine in Alzheimer's diseaseDrugs to treat age-related neurodegenerative problems. The final frontier of medical science?Memantine in dementia: a review of the current evidence.New developments on the role of NMDA receptors in Alzheimer's diseaseAlzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connectionsCalcium channel blockers and dementia.Multi-target design strategies in the context of Alzheimer's disease: acetylcholinesterase inhibition and NMDA receptor antagonism as the driving forces.NMDA and AMPA receptors in transgenic mice expressing human beta-amyloid protein.MK-801-Treated Oligodendrocytes as a Cellular Model to Study Schizophrenia.Multitarget strategies in Alzheimer's disease: benefits and challenges on the road to therapeutics.VEGF receptor antagonist Cyclo-VEGI reduces inflammatory reactivity and vascular leakiness and is neuroprotective against acute excitotoxic striatal insult.Tumor necrosis factor alpha stimulates NMDA receptor activity in mouse cortical neurons resulting in ERK-dependent death.Progress in the development of new drugs in Alzheimer's disease.Presenilin 1 promotes trypsin-induced neuroprotection via the PAR2/ERK signaling pathway. Effects of presenilin 1 FAD mutations.How do Soluble Oligomers of Amyloid beta-protein Impair Hippocampal Synaptic Plasticity?Longitudinal imaging reveals subhippocampal dynamics in glutamate levels associated with histopathologic events in a mouse model of tauopathy and healthy mice.New pharmacological strategies for cognitive enhancement using a rat model of age-related memory impairment.beta-Amyloid precursor protein mismetabolism and loss of calcium homeostasis in Alzheimer's disease.
P2860
Q24647560-F8A03F02-7AA8-4777-ABC2-FA214E17B5D3Q26786905-8F97277D-6381-4E23-89DA-6EA47A662F34Q27025207-DF7DAE49-25B6-48D0-931F-599C3CDFDE8FQ28370052-10C3C6A4-A871-4DE2-9B09-1326C51AEBF7Q30458465-C702BCC1-D70C-4A33-A513-C1FB374B116FQ31010610-7B09D17F-4705-4584-94A6-8F916F77DDBEQ33597194-024EDC63-3FA1-472A-9C6A-8118DDF1C8CDQ33714945-DAD43439-F0CC-4B45-AB8C-6D4132B76FB9Q33861011-78105690-DF1D-478F-8E53-318FB5490A53Q34133434-92A00989-BE82-41B4-8190-1B322538F71BQ34323806-973A3561-D4DD-4DEE-BB56-6238E6876FA4Q34475579-C8C77DCD-3B57-48C8-A0AF-3684BE27E44AQ34479707-51418160-8B09-4552-95B9-E098D90A3C5CQ34550307-7F778DB5-C5DC-46A6-82B4-D8593CF3759EQ35306297-5041EEDE-DA98-4B23-AE42-DFC2FBA18D42Q35485363-DBE396A3-1A4F-4450-9AD8-EFFFD3F64ECBQ36401406-7969C64F-0985-4EB1-AF1D-B3F83FF07FFEQ36475830-E7095A24-26DF-4087-84E0-129690435E3BQ36524290-46420FED-1CF4-4E4E-8B61-81DC1102D71CQ37160164-7049A191-8E7A-4C0A-9FAC-F1C70B3FD625Q37234077-5016F7EA-13E8-4614-B7FE-26657ECF7F4CQ37385567-8944613C-9089-4F80-9250-1E0FABA9606BQ37402673-49CF706C-DD96-47C3-9E43-253FD348C1F5Q37591162-9A96CEEB-0A18-436D-A5D9-C4C09E2A76D5Q37850821-016882C3-52C9-4721-BF19-14028A7369B8Q37941166-23C8984D-0A64-4B3C-B8A7-1A97DFAD65E6Q38014513-EA0CAE56-C87C-4553-A725-F09CAC392C62Q38103603-D78E7DB4-7BC8-40A6-A0D4-CF8D01FFA7E5Q38184970-FB129872-8886-4254-8D37-E18D8C52BE3EQ38314057-FB81EEB4-5439-4138-9B50-CF0E7C04D807Q38709794-77E4FFE0-4AA7-4828-A44B-4F4F776CC575Q38881147-82EFAEB4-ADC3-49F6-AB10-1D7BF9190129Q39249401-C1AF41CE-5087-41EB-A4EE-F4C68832FC82Q39668898-AD5CC4CD-FC82-4790-8F8F-D5947509011BQ39789745-894D883F-7DB5-43D4-A7E4-C744C8FE7477Q39796754-CA62CEFA-8431-49B6-8744-DC6062F2D43AQ40201381-935DE5CD-EB1D-4714-8971-9300CCA9045DQ40415700-61BE1213-79CA-4292-B843-74172EE2AFFAQ40671188-A8F4847C-29B1-49F9-B07D-5CD5DD274346Q40779592-8FFCCF6B-AA8D-40DB-A4BA-499DA3C883AF
P2860
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Excitatory amino acids and Alzheimer's disease.
@en
type
label
Excitatory amino acids and Alzheimer's disease.
@en
prefLabel
Excitatory amino acids and Alzheimer's disease.
@en
P1476
Excitatory amino acids and Alzheimer's disease.
@en
P2093
Greenamyre JT
P304
P356
10.1016/0197-4580(89)90143-7
P577
1989-09-01T00:00:00Z